Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
about
Recent advances in understanding antitumor immunityImmunoNodes - graphical development of complex immunoinformatics workflowsExome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.Evaluation of computational programs to predict HLA genotypes from genomic sequencing data.MICADo - Looking for Mutations in Targeted PacBio Cancer Data: An Alignment-Free MethodDifferential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancerMultilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous MelanomaEvolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.FRED 2: an immunoinformatics framework for Python.Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).High-Accuracy HLA Type Inference from Whole-Genome Sequencing Data Using Population Reference GraphsImmunoinformatics and epitope prediction in the age of genomic medicine.MuPeXI: prediction of neo-epitopes from tumor sequencing data.Genomic Correlates of Immune-Cell Infiltrates in Colorectal CarcinomaCancer immunotherapy targeting neoantigens.Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancerClonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.Landscape of tumor-infiltrating T cell repertoire of human cancersTumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.Unmasking targets of antitumor immunity via high-throughput antigen profiling.Expression of classical HLA class I molecules: regulation and clinical impacts: Julia Bodmer Award Review 2015.Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.Computational genomics tools for dissecting tumour-immune cell interactions.Immunoregulatory functions of VISTA.Current tools for predicting cancer-specific T cell immunity.Genomic Approaches to Understanding Response and Resistance to Immunotherapy.Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.Applications of Immunogenomics to Cancer.Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors.Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.DNA Damage and Repair Biomarkers of Immunotherapy Response.Predicted neoantigen load in non-hypermutated endometrial cancers: Correlation with outcome and tumor-specific genomic alterations.Extracting replicable associations across multiple studies: Empirical Bayes algorithms for controlling the false discovery rate.Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
P2860
Q28067217-B03B3C05-AA96-4805-B0FD-A526B22DC168Q30250980-7844079D-7BBB-4141-8F73-E250D2575270Q30388270-263E3720-286A-4206-868A-D428E5C1E24FQ30762699-3B4E9A8B-3265-4249-9944-F6FAA90B130FQ31117752-BC272369-7733-493A-BA56-ED5D7BC42B91Q31140417-87747E99-B496-4E23-9FD8-FE96CD78EDF5Q31150879-51F48A73-9E50-477D-9D53-CF23DA82822CQ33576409-8E8F63B8-6021-4946-93B5-F36F19A22957Q33722799-462A1305-52B3-423D-86C1-6C2140A0EC84Q33741471-7DBC7891-9648-46C5-87C1-388FC98CC221Q34529131-042AE409-46D3-46CF-AD4A-47D1399F9A21Q36011145-75D4E87F-AAB8-4113-8509-63D2138A3A8AQ36024656-06D2E7FA-4CC1-4863-9363-29BA29B3B4EFQ36177087-B8C5B9DF-1F44-414B-9940-AC884D156415Q36304147-820FBC83-08D0-40E2-B6BE-5CB08A392FE1Q36352986-9C5A9AEE-8C2A-42C1-8064-C328975E369EQ36850230-144BBA6B-6240-4DDD-BD29-A93055336A14Q36889067-83889F22-CBF4-4759-8A82-19B4CB9307C5Q37046405-3A698D04-1C2B-4DE0-9819-E1E5AD41D154Q37173548-56C04FAE-1333-428D-85A3-5B3DBCF502A2Q37526352-2CAA0BA9-6E8B-4822-B20C-05D3E7340868Q37632809-7CBC65E1-0433-4E8B-8AE3-4879D139CBC4Q38730989-4ED59C0D-3306-491C-B3D3-C6E709A3300EQ38753386-D4301A43-CB91-4F4A-8E63-6505D389E4C2Q38787035-48BD1140-DEA0-4CF8-ABF9-2FB405E6C827Q38802673-68833C48-4D5D-4C75-AD0A-02BD5093737EQ38875037-34C8D326-4F15-4826-8660-6AF15F476361Q38885361-2BA8E667-2B0C-425D-8735-AE6E4B6A6A36Q38930123-BD3B837D-B966-4695-B4A6-E55F27BD61CAQ38953021-39798E63-2395-42E4-93A5-2279529E84EAQ38971262-B9127609-511C-4EAE-8FA2-CDB826A02664Q39092611-EBA17033-969A-4491-9E06-6051E29DB0F1Q39130420-84879CCA-3B11-4565-B48C-2F01C1A50758Q39157730-65E44CA1-206F-4A04-A728-15CF03C68C20Q39243052-B7F04251-8016-4BB2-B51E-ED2A4441A678Q39384263-13FCEEF8-640F-4219-8332-6A9057E51284Q40945342-AE0ABFF3-5047-4C6A-B0ED-0E68C5676695Q41561831-0A6C9A72-5EB2-4547-BCA7-CCDC8C1CFE4DQ41571576-C878C8DE-25E4-4826-B093-6CE56AD68535Q41596176-AC028B22-4F90-47A2-A679-179BB0AA7621
P2860
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
@ast
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
@en
type
label
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
@ast
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
@en
altLabel
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
@en
prefLabel
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
@ast
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
@en
P2093
P2860
P50
P356
P1433
P1476
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
@en
P2093
Adam Kiezun
Catherine J Wu
Grace Tiao
Jamie L Dellagatta
Jonathan Stevens
Michael S Lawrence
Michael S Rooney
Mohini Rajasagi
Philip M Dixon
Sachet A Shukla
P2860
P2888
P304
P356
10.1038/NBT.3344
P407
P577
2015-09-15T00:00:00Z
P6179
1005491724